CLOs on the Move

Mycometrics

www.mycometrics.com

 
Mycometrics is a Monmouth Junction, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Bendiner and Schlesinger Inc

Bendiner & Schlesinger, Inc. provides a level of customer service that's rare in business today. We have the facilities and expertise to execute competitively-priced institutional contracts that offer economies of scale and the delivery of services to

Synbiotics Corporation

Synbiotics Corporation offers a wide selection of canine reproductive services and products to breeders and veterinarians across the globe. Using advanced technology developed through years of research by leading scientists and veterinary specialists,

Paradigm Spine

Paradigm Spine is a provider of non-fusion and fusion spinal implant solutions that serve to address the unmet clinical needs of spine surgeons and their patients. Starting with the coflex® Interlaminar Stabilization® device, Paradigm Spine develops a full non-fusion product portfolio of motion preserving, tissue sparing technologies, as well as fusion products. It is our commitment to lead the positioning of non-fusion technologies to the forefront of improving the quality of life in patients with spinal diseases through being

Infinity Laboratories

Infinity Laboratories was founded in 1991 on the bedrock principles of excellence, integrity, and quality. Today, the Company is a national chemical and microbiological testing laboratory servicing the medical device and pharmaceutical industries. Infinity Labs was recently named one of Colorado`s top innovative companies by the nonprofit Colorado Companies to Watch honors 50 firms each year for their innovative work. Infinity Laboratories was chosen out of a field of more than 1,000 Colorado companies.

Magellan Biosciences

History and background - Magellan Biosciences, Inc. was established in October 2004 through the combination of ESA Biosciences and Dynex Technologies - which addressed emerging growth markets in biomedical research and clinical diagnostics. In November